Abstract:Introduction: Novel preventive strategies in periodontal disease target the bacterial-induced inflammatory host response to reduce associated tissue destruction. Strategies focus on the modulation of tissue-destroying inflammatory host response, particularly the reduction of inflammation and promotion of resolution. Thereby, nutrition is a potent immunometabolic non-pharmacological intervention. Human studies have demonstrated the benefit of olive oil-containing Mediterranean-style diets (MDs), the main component of which being mono-unsaturated fatty acid (FA) oleic acid (OA (C18:1)). Hence, nutritional OA strengthened the microarchitecture of alveolar trabecular bone and increased circulating pro-resolving lipid mediators following bacterial inoculation with periodontal pathogen Porphyromonas gingivalis, contrary to saturated FA palmitic acid (PA (C16:0)), which is abundant in Western-style diets. Additionally, the generalized distribution of inflammatory pathway mediators can occur in response to bacterial infection and compromise systemic tissue metabolism and bone homeostasis distant from the side of infection. Whether specific FA-enriched nutrition and periodontal inoculation are factors in systemic pathology that can be immune-modulatory targeted through dietary substitution is unknown and of clinical relevance. Methods: Normal-weight C57BL/6-mice received OA-or PA-enriched diets (PA-ED, OA-ED, PA/OA-ED) or a normal-standard diet (n=12/group) for 16 weeks and were orally infected with P. gingivalis/placebo to induce periodontal disease. Using histomorphometry and LC-MS/MS, systemic bone morphology, incorporated immunometabolic FA-species, serological markers of bone metabolism, and stress response were determined in addition to bone cell inflammation and interaction in vitro. Results: In contrast to OA-ED, PA-ED reduced systemic bone microarchitecture paralleled by increased lipotoxic PA-containing metabolite accumulation in bone. Substitution with OA reversed the bone-destructive impact of PA, which was accompanied by reduced diacylglycerols (DAG) and saturated ceramide levels. Further, PA-associated reduction in mineralization activity and concomitant pro-inflammatory activation of primary osteoblasts were diminished in cultures where PA was replaced with OA, which impacted cellular interaction with osteoclasts. Additionally, PA-ED increased osteoclast numbers in femurs in response to oral P. gingivalis infection, whereas OA-ED reduced osteoclast occurrence, which was paralleled by serologically increased levels of the stress-reducing lipokine PI(18:1/18:1). Conclusion: OA substitution reverses the bone-destructive and pro-inflammatory effects of PA and eliminates incorporated lipotoxic PA metabolites. This supports Mediterranean-style OA-based diets as a preventive intervention to target the accumulation of PA-associated lipotoxic metabolites and thereby supports systemic bone tissue resilience after oral bacterial P. gingivalis infection.

Potential of alveolar bone damage in periodontitis patients with dyslipidemia

Aberrant Periodontal and Systemic Immune Response of Overweight Rodents to Periodontal Infection.

[Research Progress on the Regulatory Cell Death of Osteoblasts in Periodontitis].

Disruption of cholesterol homeostasis triggers periodontal inflammation and alveolar bone loss

Acceleration of HDL-mediated cellular cholesterol efflux alleviates periodontitis

The association between high-density lipoproteins and periodontitis

Acceleration of HDL-Mediated Cholesterol Efflux Alleviates Periodontitis

Lipoprotein-associated Phospholipase A2 and Serum Lipid Levels in Subjects with Chronic Periodontitis and Hyperlipidaemia

Wnt signaling: An attractive target for periodontitis treatment

Plasma lipid and blood glucose levels in patients with destructive periodontal disease

Effect of Hyperlipidemia on Periodontitis Progress in Apolipoprotein E Knockout Mice

Diabetic periodontitis: possible lipid-induced defect in tissue repair through alteration of macrophage phenotype and function

Periodontal therapy improved lipoprotein-associated phospholipase A2 and lipid levels in serum of chronic periodontitis subjects with hyperlipidemia

Hyperlipidemia Causes Changes in Inflammatory Responses to Periodontal Pathogen Challenge: Implications in Acute and Chronic Infections

The Association between Periodontal Status, Serum Lipid Levels, Lipoprotein Associated Phosholipase A2 (Lp-PLA2) in Chronic Periodontitis Subjects and Healthy Controls

The Effect of Hyperlipidemia on Peri-implant Health: A Clinical and Radiographical Prospective Study

Association of simvastatin and hyperlipidemia with periodontal status and bone metabolism markers

Osteoporosis and Alveolar Bone Health in Periodontitis Niche: A Predisposing Factors-Centered Review

Lipotoxicity: The missing link between diabetes and periodontitis?

The roles of osteocytes in alveolar bone destruction in periodontitis

Immunometabolic capacities of nutritional fatty acids in regulation of inflammatory bone cell interaction and systemic impact of periodontal infection